Allied Market Research recently published a report, titled, “Global Male Hypogonadism Market by Drug Delivery (Topical Gels, Injectables, Transdermal Patches, Others), by Therapy (Testosterone Replacement Therapy, Gonadotropin and Gonadotropin Releasing Hormone Therapy), by Type (Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030.” As per the report, male hypogonadism market generated $3.1 billion in 2020, and is expected to reach $5.1 billion by 2030, witnessing a CAGR of 5.1% from 2021 to 2030.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/1874
Male Hypogonadism Market Overview:
Increase in prevalence and incidence of testosterone deficiency in males, surge in infertility rates, and rise in awareness of male hypogonadism treatment choices among the patients drive the growth of the global male hypogonadism market. However, the availability of testosterone replacement treatment (TRT) restrains the market growth. On the other hand, technological developments present new opportunities in the coming years.
Male Hypogonadism Market Segmentation:
On the basis of therapy, the testosterone replacement therapy segment held the largest market share in 2020, contributing to nearly two-thirds of the global male hypogonadism market, and is expected to maintain its leadership status in terms of revenue by 2030. However, the gonadotropin and gonadotropin releasing hormone therapy segment is projected to manifest the largest CAGR of 6.1% during the forecast period.
On the basis of type, the pituitary disorders segment contributed to the highest share in 2020, accounting for nearly half of the total market share, and is projected to maintain its lead position during the forecast period. Moreover, this segment is expected to register the highest CAGR of 5.8% from 2021 to 2030. The report also analyzes the segments including klinefelters syndrome, kallmann syndrome, and others.
On the basis of region, North America accounted for the highest share in 2020, contributing to nearly half of the total market share, and is projected to continue its leadership status by 2030. However, Asia-Pacific is projected to portray the fastest CAGR of 7.9% during the forecast period.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/1874
Male Hypogonadism Market: By Region Outlook
North America (U.S., Canada)
Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
Important Questions Being Answered by the Male Hypogonadism Market Report:
What is the Male Hypogonadism market size and growth?
What are the prominent and latest trends impacting the market?
Which is the largest regional market for Male Hypogonadism?
Leading players of the global male hypogonadism market analyzed in the research include Allergan PLC., Eli Lily & Company, Bayer AG, Ferring Holdings SA, Endo Iternational PLC., Merck & Co. Inc., Finox Biotech, Perrigo Company PLC., Pfizer, and Teva Pharmaceutical Industries Ltd.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest.”
Top Trending Report:-
Companion Diagnostic Market Size, Share & Growth Outlook 2022-2030
Regenerative Medicine Market Size, Share & Growth Outlook 2022-2030
Wearable Patch Market Size, Share & Growth Outlook 2022-2030
Dental Implants and Prosthetics Market Size, Share & Growth Outlook 2022-2030
IVF Devices and Consumables Market Size, Share & Growth Outlook 2022-2030
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.